Bristol Myers Squibb will build at Generation Park a 600,000-square-foot campus. The pharmaceutical project is expected to generate about 2,000 construction jobs and related activities between 2027 and 2030.
Bristol Myers Squibb chose Generation Park, in the northeast of Houston, to build a pharmaceutical plant with an approximate investment of $2.3 billion and nearly 500 permanent jobs.
The project will be located in Harris County, within a 4,300-acre development dedicated to advanced manufacturing and health sciences companies. The facility will have the capacity to produce different types of medicines and to expand its operations as the company’s needs grow.
The pharmaceutical company selected Houston after evaluating several locations in the central and eastern United States. Among the factors considered were the available workforce, access to utilities and transportation, and economic incentives.
The construction and start-up of the pharmaceutical will span 2027 to 2030
The campus will occupy approximately 600,000 square feet during its first phase. Its modular design will allow adding buildings, equipment, or production lines without having to redo the entire facility.
The plant will be able to manufacture small-molecule drugs, biologics, and antibody-drug conjugates. The latter combine an antibody with a drug to deliver treatment directly to specific cells.
Bristol Myers Squibb estimates that construction and related activities will sustain approximately 2,000 jobs between 2027 and 2030. That figure is separate from the nearly 500 permanent positions expected to operate the campus once it comes online.
The company has not set an exact opening date, though it expects to build and commission the facilities during that period. Official project details are available on Bristol Myers Squibb’s website.
Positions at the pharmaceutical will cover manufacturing, engineering, and quality control
The initial workforce will include operations technicians, production specialists, maintenance personnel, engineers, quality control and quality assurance professionals, administrators, and executives.
A public filing submitted to the Texas Comptroller’s Office estimates 489 new hires. The document distributes these roles between 2027 and 2031, but the company has not publicly confirmed that it will maintain that annual schedule.
As of August 10, Bristol Myers Squibb had not published salaries, requirements, or a specific job posting for the Houston plant. The company’s official careers portal lists its active vacancies, but it does not yet have a separate page for the Generation Park project.
Nearly 500 jobs correspond to the campus’s initial configuration. The design contemplates future expansions that could increase production capacity and the number of workers.
Texas offered $4.89 million through an incentive fund
Texas offered Bristol Myers Squibb a $4.89 million grant from the Texas Enterprise Fund. This program ties its payments to meeting commitments to invest and create jobs in projects that compete with locations in other states.
The plant also meets the conditions to participate in the state’s Jobs, Energy, Technology and Innovation program, known as JETI. This mechanism allows limiting for a defined period the taxable value of property on which a school district charges taxes.
The public file identifies applicants as E.R. Squibb & Sons LLC and Sheldon ISD. As of August 10, the filing appeared still in the application phase with the Texas Comptroller; therefore, that potential tax relief should not be presented as a finalized agreement.
Bristol Myers Squibb has not yet assigned a public street address to the site nor set the date for the first hires for the campus.
